Original language | English (US) |
---|---|
Pages (from-to) | e416-e418 |
Journal | Haematologica |
Volume | 103 |
Issue number | 9 |
DOIs | |
State | Published - Aug 31 2018 |
ASJC Scopus subject areas
- Hematology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Haematologica, Vol. 103, No. 9, 31.08.2018, p. e416-e418.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
AU - Strati, Paolo
AU - Chihara, Dai
AU - Oki, Yasuhiro
AU - Fayad, Luis E.
AU - Fowler, Nathan
AU - Nastoupil, Loretta
AU - Romaguera, Jorge E.
AU - Samaniego, Felipe
AU - Garg, Naveen
AU - Feng, Lei
AU - Wesson, Emily T.
AU - Ruben, Charnelle E.
AU - Stafford, Mildred D.
AU - Nieto, Yago
AU - Khouri, Issa F.
AU - Hosing, Chitra
AU - Horowitz, Sandra B.
AU - Kamble, Rammurti T.
AU - Fanale, Michelle A.
N1 - Funding Information: 1Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX;2Department of Internal Medicine, University of New Mexico, Albuquerque, NM;3Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX;4Department of Diagnostic Radiology, MD Anderson Cancer Center, Houston, TX; 5Department of Biostatistics, MD Anderson Cancer Center, Houston, TX;6Department of Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX and 7Department of Hematology-Oncology, Baylor College of Medicine and Houston Methodist Hospital, TX, USA *PS and DC contributed equally to this manuscript. Funding: this work was supported in part by The MD Anderson Cancer Center Support Grant (P30 CA016672). Correspondence: mfanale@mdanderson.org; doi:10.3324/haematol.2018.187617 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.
PY - 2018/8/31
Y1 - 2018/8/31
UR - http://www.scopus.com/inward/record.url?scp=85052896032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052896032&partnerID=8YFLogxK
U2 - 10.3324/haematol.2018.187617
DO - 10.3324/haematol.2018.187617
M3 - Letter
C2 - 29622656
AN - SCOPUS:85052896032
SN - 0390-6078
VL - 103
SP - e416-e418
JO - Haematologica
JF - Haematologica
IS - 9
ER -